Bench to bedside for cancer

By Staff Writers
Friday, 06 February, 2009


Five Melbourne-based cancer research organisations have come together to form a new integrated cancer research facility, based at the Walter and Eliza Hall Institute at Parkville.

WEHI is joined by the Ludwig Institute, the Royal Women’s Hospital, the Royal Melbourne Hospital and the University of Melbourne in the $5 million facility.

Established with a $5 million grant from the Australian Cancer Research Foundation, the new ACRF Centre for Therapeutic Target Discovery (CTTD) aims to share human and material resources to further cancer research, predominantly in bowel, breast and blood cancers.

The money will be used to purchase new equipment, including:

  • A mouse RNA interference library

  • A Cell Sorter and Cell Analyser from BD for flow cytometry

  • A live cell imaging microscope from Zeiss and a deep cell imaging microscope from Olympus

  • A Bond-maX Cell Stainer and a fresh tissue embedder from Leica for molecular pathology, along with a Veritas automated tissue laser

  • A Xenogen IVIS Spectrum animal imager and a BD Pathway 855 system for imaging

  • An Eppendorf Automatic Dispensing System, a BMG Labtech FLUOstar microplate reader and Applied Biosystems thermal cyclers for systems biology.
Related Articles

Eight babies born in UK following mitochondrial donation

The birth of eight babies with a greatly reduced risk of developing mitochondrial DNA disease...

'Directed evolution' used to design molecules in mammal cells

Scientists have developed a system that uses so-called 'biological artificial...

Novel drug candidates found for nerve pain and ischemic disease

The discovery paves the way for potential new treatments for health conditions linked to tissue...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd